An audit of people admitted to hospital with diabetes and coronavirus (SARS-CoV-2): data collection methods. The Association of British Clinical Diabetologists (ABCD) Nationwide Audit

Authors

  • Dinesh Nagi Edna Coates Diabetes and Endocrine Unit, Pinderfields Hospital, Mid Yorkshire NHS Trust Wakefield
  • Robert EJ Ryder Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
  • Yue Ruan Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, UK Oxford NIHR Biomedical Research Centre, UK
  • Benjamin CT Field Department of Clinical & Experimental Medicine, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK (ORCiD 0000-0002-1883-1588) Department of Diabetes & Endocrinology, Surrey & Sussex Healthcare NHS Trust, Redhill, Surrey, UK
  • Parth Narendran Medical and Dental Sciences, University of Birmingham, Birmingham, UK Diabetes Centre, The Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Rajiv Gandhi Department of Diabetes & Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust, UK
  • Sophie Harris Diabetes and Endocrinology Department, King’s College Hospital, UK
  • Kinga A Várnai Oxford NIHR Biomedical Research Centre, UK 1Oxford University Hospitals NHS Foundation Trust, UK
  • Jim Davies Oxford NIHR Biomedical Research Centre, UK Department of Computer Science, University of Oxford
  • Sarah H Wild Usher Institute, University of Edinburgh, Edinburgh, UK
  • Emma G Wilmot Diabetes Department, University Hospitals of Derby and Burton NHS FT, Derby, UK University of Nottingham, Nottingham, UK
  • Kamlesh Khunti University Hospitals of Leicester NHS Trust, Diabetes Research Centre, Leicester General Hospital
  • Rustam Rea Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, UK Oxford NIHR Biomedical Research Centre, UK

DOI:

https://doi.org/10.15277/bjd.2021.299

Keywords:

COVID-19, diabetes, pandemic, COVID-Audit, risk factors and mortality, ABCD nationwide Audit

Abstract

We describe the rationale, aims and objectives and the methodology of data collection for the ABCD nationwide audit of individuals admitted to hospital with coronavirus (SARS-CoV-2; COVID-19) and diabetes. The audit was inspired and undertaken by the urgent need to understand the clinical course of COVID-19 in patients with diabetes admitted to hospital in the UK during the pandemic. We wished to understand the clinical behaviour of diabetes per se, post hospital admission and the factors with may be associated with admission to the Intensive Care Unit (ICU) and death due to COVID-19. This was a clinically-led audit. We used existing infrastructure and expertise to collect data using an electronic tool specifically designed and piloted by the steering group members. The clinical variables were chosen to fulfil the main aim of this audit as stated above, and factors influencing the clinical course of COVID-19 in individuals with both type 1 and type 2 diabetes at the time of admission to hospital and during the whole length of stay, until discharge or death from COVID-19. The data collected so far represent a large, multicentre audit with more than 3,500 admissions during the pandemic. We plan to continue collecting additional data and publish ongoing reports of interest to diabetes clinicians with the aim of enhancing knowledge and understanding and thereby improving clinical care of, and outcomes for, people with diabetes who are admitted to hospital with COVID-19 in the UK.

Author Biography

Dinesh Nagi, Edna Coates Diabetes and Endocrine Unit, Pinderfields Hospital, Mid Yorkshire NHS Trust Wakefield

Honorary Consultant in Diabetes & Endocrinology

References

Worldometer. Coronavirus. Available from: https://www.worldometers.info/coronavirus [Accessed 2 March 2021].

Singh AK, Gillies CL, Singh R, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab 2020;22(10):1915–24. https://doi.org/10.1111/dom.14124

Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol 2020;8(10):813–22. https://doi.org/10.1016/S2213-8587(20)30272-2

Marfella R, Paolisso P, Sardu C, et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab 2020; 46(5):403–5. https://doi.org/10.1016/j.diabet.2020.05.005

Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab 2020;22(10):1897–906. https://doi.org/10.1111/dom.14099

Wang S, Ma P, Zhang S, et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia 2020;63(10):2102–11. https://doi.org/10.1007/s00125-020-05209-1

Ebekozien OA, Noor N, Gallagher MP, Alonso GT. Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S. Diabetes Care 2020;43(8):e83–e85. https://doi.org/10.2337/dc20-1088

Wargny M, Gourdy P, Ludwig L, et al. Type 1 diabetes in people hospitalized for COVID-19: new insights from the CORONADO study. Diabetes Care 2020;43(11):e174–e177. https://doi.org/10.2337/dc20-1217

Vamvini M, Lioutas VA, Middelbeek RJW. Characteristics and diabetes control in adults with type 1 diabetes admitted with COVID-19 infection. Diabetes Care 2020;43(10):e120–122. https://doi.org/10.2337/dc20-1540

Wargny M, Potier L, Gourdy P, et al. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia (published online 17 Feb 2021). https://doi.org/10.1007/s00125-020-05351-w

NIHR Health Informatics Collaborative. Available from: https://hic.nihr.ac.uk/ [Accessed 2 March 2021].

Association of British Clinical Diabetologists (ABCD). The history of the ABCD nationwide and worldwide audit programme. Available from: http://www.diabetologists-abcd.org.uk/n3/previous_ABCD_audits.htm [Accessed 2 March 2021].

Association of British Clinical Diabetologists (ABCD). ABCD Nationwide and Worldwide Audit Programme Publications. Available from: https://abcd.care/abcd-nationwide-and-worldwide-audit-programme-publications [Accessed 2 March 2021].

Association of British Clinical Diabetologists (ABCD). Launch of the Covid-19 and diabetes ABCD national audit. Available from: https://abcd.care/announcement/launch-covid-19-and-diabetes-abcd-national-audit (Accessed 2 March 2021].

Oxford University Hospitals. Is my project research? Available from: https://www.ouh.nhs.uk/researchers/planning/is-it-research/ [Accessed 2 March 2021].

Association of British Clinical Diabetologists (ABCD). ABCD COVID-19 and Diabetes: UK national audit. Available from: http://www.diabetologists-abcd.org.uk/Coronavirus/COVID-19._Diabetes_Nationwide_Audit.htm [Accessed 2 March 2021].

Downloads

Published

2021-05-28

Issue

Section

Learning from practice

Most read articles by the same author(s)

<< < 1 2 3 4 5